Suppr超能文献

中文心力衰竭患者植入式心脏复律除颤器治疗预防心源性猝死的一级预防:单中心经验。

Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.

机构信息

Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.

出版信息

Chin Med J (Engl). 2010 Apr 5;123(7):848-51.

Abstract

BACKGROUND

An implantable cardioverter-defibrillator (ICD) has been suggested for heart failure patients for primary prevention of sudden cardiac death. However, few data have been reported on the application of ICD as primary prevention of sudden cardiac death in China. We evaluated the value of primary prevention ICD therapy in Chinese patients with heart failure.

METHODS

Thirty-four patients at an average age of (60.2 +/- 13.7) years seen in Peking Union Medical College Hospital were treated with ICD implantation for primary prevention of sudden cardiac death from November 2005 to July 2009. Single-chamber ICDs were implanted in 16 (47.0%) cases, and dual-chamber or cardiac resynchronization therapy defibrillators in 18 (53.0%) cases. The patients had an average left ventricular ejection fraction of (26.9 +/- 5.5)% (11% to 35%), of which 18 (53.0%) patients had ischemic cardiomyopathy and 16 (47.0%) patients had non-ischemic cardiomyopathy. All patients were followed up at three months after the implantation and every six months thereafter or when prompted by an ICD event.

RESULTS

There were five (14.7%) deaths, including two of heart failure and three with a non-cardiac course, during an average follow-up of (15.0 +/- 11.9) months. Forty-one ICD therapy events were recorded, including 19 (46.3%) appropriate ICD therapies in six patients and 22 (53.7%) inappropriate ICD therapies in four patients with single chamber leads. Inappropriate ICD therapies were mainly due to supraventricular tachyarrhythmias, especially atrial fibrillation. Patients with ischemic cardiomyopathy and non-ischemic cardiomyopathy did not differ in the incidence of either appropriate or inappropriate therapy.

CONCLUSIONS

ICD for primary prevention of sudden cardiac death in China prevents patients from arrhythmia death. Relatively high incidence of inappropriate therapies highlights the importance of an atrial lead.

摘要

背景

植入式心脏复律除颤器(ICD)已被建议用于心力衰竭患者的心脏性猝死的一级预防。然而,在中国,关于 ICD 用于心脏性猝死一级预防的应用数据很少。我们评估了 ICD 作为中国心力衰竭患者心脏性猝死一级预防的价值。

方法

2005 年 11 月至 2009 年 7 月,北京协和医院共 34 例平均年龄(60.2+/-13.7)岁的心力衰竭患者接受 ICD 植入以预防心脏性猝死。其中 16 例(47.0%)患者植入单腔 ICD,18 例(53.0%)患者植入双腔或心脏再同步治疗除颤器。患者平均左心室射血分数为(26.9+/-5.5)%(11%至 35%),其中 18 例(53.0%)患者为缺血性心肌病,16 例(47.0%)患者为非缺血性心肌病。所有患者在植入后 3 个月和此后每 6 个月或 ICD 事件发生时进行随访。

结果

平均随访(15.0+/-11.9)个月期间,共有 5 例(14.7%)患者死亡,其中 2 例死于心力衰竭,3 例非心脏性疾病。共记录到 41 次 ICD 治疗事件,包括 6 例患者的 19 次(46.3%)适当 ICD 治疗和 4 例患者的 22 次(53.7%)单腔导线不适当 ICD 治疗。不适当的 ICD 治疗主要是由于室上性心动过速,尤其是心房颤动。缺血性心肌病和非缺血性心肌病患者的适当和不适当治疗的发生率无差异。

结论

中国 ICD 用于心脏性猝死的一级预防可预防心律失常性死亡。不适当治疗的发生率较高突出了心房导线的重要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验